Colorectal Cancer Trial, Recruiting NCT05528783 Sponsor: Sun Yat-sen University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05528783
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with colorectal cancer (a specific type called adenocarcinoma) confirmed by a lab test
  • You are between 18 and 80 years old (any gender)
  • You are scheduled to have surgery to fully remove your colorectal cancer
  • You have not received any cancer treatments before surgery, such as chemotherapy, radiation, targeted therapy, or immunotherapy
  • Tests done before surgery show that your cancer has not spread to other parts of the body
  • You do not have severe hemorrhoids or other known conditions that cause bleeding in the gut before surgery
  • Your full medical treatment records are available and complete

Who may not be able to join:

  • You have a history of a different digestive tract cancer (other than colorectal cancer)
  • You have had previous surgery on your colon or rectum
  • You need a stoma (an opening created in the abdomen to redirect waste) as part of your surgery (confirm with trial site)
  • You have a complete blockage or a tear/hole in your bowel
  • You are currently pregnant or breastfeeding
  • During surgery, cancer is found to have spread to other areas that cannot be fully removed
  • You are unwilling or unable to sign a consent form agreeing to take part
  • You follow a strict vegetarian diet
  • You are unwilling or unable to attend follow-up appointments as required by the study
  • The study doctor decides for any other reason that joining the trial would not be appropriate for you

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-13802446666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 April 2022
Est. completion
30 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The diagnostic sensitivity and specificity of FIT-DNA detection for local recurrence and advanced colorectal neoplasm of CRC.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov